Abstract
Background
Maturity-onset Diabetes of the Young type 5 (MODY5) is clinically heterogeneous, and the genetic examination is important to provide the accurate diagnosis. Identification of more cases will better understand the genotype-phenotype correlations of this disorder.
Methods
We collected the clinical and biochemical data, using the whole-exome gene detection and multiplex ligation–dependent probe Amplification to detect the pathogenic gene variants.
Results
The proband is a 39-year-old female, and presenting with symptoms including polyuria, polydipsia, and weight loss for 6 months. Her BMI was 17.6 kg/m2. Laboratory tests indicated hypokalemia (3.1 mmol/L), hypomagnesemia (0.4 mmol/L), and hypocalcemia (1.91 mmol/L). Glycated hemoglobin (HbA1c) was 13.7%, fasting C-peptide was 0.24 ng/mL (normal range: 0.3–3.73 ng/mL). Both glutamic acid decarboxylase and islet cell antibodies were negative. Abdominal magnetic resonance image showed the agenesis of the tail and body of the pancreas and the presence of disseminated cysts of the left kidney. Genetic examination displayed a de novo heterozygous deletion of the whole HNF-1Β gene (NM_000458.3). Three-year follow-up after the diagnosis showed that the patient has sustained hypomagnesemia and cannot maintain an appreciable increase in serum magnesium levels (0.52–0.61 mmol/L), although she was using the double-dose magnesium aspartate. Moreover, she cannot achieve good glucose control either.
Conclusion
Our findings indicted that MODY is highly heterogeneous and patients with additional extrapancreatic clinical features and hypomagnesemia should be screened for MODY5.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this published article.
References
Fajans SS, Bell GI. MODY: history, genetics, pathophysiology, and clinical decision making. Diabetes Care. 2011;34(8):1878–84. https://doi.org/10.2337/dc11-0035.
Clissold RL, Hamilton AJ, Hattersley AT, Ellard S, Bingham C. HNF1Β-associated renal and extra-renal disease-an expanding clinical spectrum. Nature reviews. Nephrology. 2015;11(2):102–12. https://doi.org/10.1038/nrneph.2014.232.
El-Khairi R, Vallier L. The role of hepatocyte nuclear factor 1beta in disease and development. Diabetes Obes Metab. 2016;18(Suppl 1):23–32. https://doi.org/10.1111/dom.12715.
Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN, et al. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet. 1997;17(4):384–5. https://doi.org/10.1038/ng1297-384.
Stiles CE, Thuraisingham R, Bockenhauer D, Platts L, Kumar AV, Korbonits M. De novo HNF1 homeobox B mutation as a cause for chronic, treatment-resistant hypomagnesemia. Endocrinol Diabetes Metab Case Rep. 2018;2018. https://doi.org/10.1530/EDM-17-0120.
Bockenhauer D, Jaureguiberry G. HNF1Β-associated clinical phenotypes: the kidney and beyond. Pediatr Nephrol. 2016;31(5):707–14. https://doi.org/10.1007/s00467-015-3142-2.
Heuvel-Borsboom H, de Valk HW, Losekoot M, Westerink J. Maturity onset diabetes of the young: seek and you will find. Neth J Med. 2016;74(5):193–200.
Raile K, Klopocki E, Holder M, Wessel T, Galler A, Deiss D, et al. Expanded clinical spectrum in hepatocyte nuclear factor 1b-maturity-onset diabetes of the young. J Clin Endocrinol Metab. 2009;94(7):2658–64. https://doi.org/10.1210/jc.2008-2189.
Laffargue F, Bourthoumieu S, Llanas B, Baudouin V, Lahoche A, Morin D, et al. Towards a new point of view on the phenotype of patients with a 17q12 microdeletion syndrome. Arch Dis Child. 2015;100(3):259–64. https://doi.org/10.1136/archdischild-2014-306810.
Rasmussen M, Vestergaard EM, Graakjaer J, Petkov Y, Bache I, Fagerberg C, et al. 17q12 deletion and duplication syndrome in Denmark-A clinical cohort of 38 patients and review of the literature. Am J Med Genet A. 2016;170(11):2934–42. https://doi.org/10.1002/ajmg.a.37848.
Mitchel MW, Moreno-De-Luca D, Myers SM, Finucane B, Ledbetter DH, Martin CL. 17q12 Recurrent Deletion Syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al., editors. GeneReviews((R)). Seattle; 1993.
Adalat S, Woolf AS, Johnstone KA, Wirsing A, Harries LW, Long DA, et al. HNF1Β mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol. 2009;20(5):1123–31. https://doi.org/10.1681/ASN.2008060633.
van der Made CI, Hoorn EJ, de la Faille R, Karaaslan H, Knoers NV, Hoenderop JG, et al. Hypomagnesemia as first clinical manifestation of ADTKD-HNF1Β: a case series and literature review. Am J Nephrol. 2015;42(1):85–90. https://doi.org/10.1159/000439286.
Acknowledgments
We thank the proband and her parents for their cooperation.
Funding
This work was supported by grants from the Fund Project of Shanghai Science and Technology Commission (No. 17401931700).
Author information
Authors and Affiliations
Contributions
Y.Z. conceived of and supervised the project, and revised the manuscript content. B.R. and Y.C. collected and analyzed the data, and drafted the manuscript. S.Z., Q.Z., J.W., and S.C. took responsibility for the integrity of the data analysis. All the authors have read and approved the final submitted version.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethics approval and consent to participate
This study was approved by the ethics institutional review board of the Laiwu Central Hospital of Xinwen Mining Group. Prior to sample collection, written informed consent was obtained from the proband and her parents.
Patient consent for publication
All subjects provided consent for publication.
Code availability
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ren, B., Chen, Y., Zhang, Q. et al. De novo mutation in HNF-1β gene as a cause for Maturity-onset Diabetes of the Young type 5 with sustained hypomagnesemia. Int J Diabetes Dev Ctries 41, 354–357 (2021). https://doi.org/10.1007/s13410-020-00904-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-020-00904-6